| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.027 | 0.9 |